Arnprior Pharmaceutical Manufacturer Set to Expand
Ontario Helping Eastern Ontario Company Create Local Jobs
Ontario is helping Pillar5 Pharma Inc. expand production at its Arnprior manufacturing facility, creating 56 new jobs and keeping 94 more in the community.
With support from the Eastern Ontario Development Fund (EODF), Pillar5 will increase its operations by installing two new, advanced production lines for the manufacturing and packaging of eye care products. This expansion will better position the company to pursue new markets -- both at home and abroad.
Providing the right climate to attract investment, create jobs and grow the economy is part of the Ontario government's plan to build a prosperous and fair province for all Ontarians.
- Since 2008, the government has committed over $63 million through the EODF, leveraging a total investment of more than $615 million.
- Canada has the second lowest cost for clinical trials and pharmaceutical production among the G7 countries.
- The pharmaceutical sector employs about 15,000 people in Ontario.
- The government passed legislation making the EODF permanent in October 2012.
“We are proud to be supporting job creation right here in eastern Ontario. This investment will help Pillar5 become a leader in the production of eye care products while expanding their markets and bringing new jobs and prosperity to the community of Arnprior.”
“We are thankful for the support from the Ontario government. This expansion means we can offer our customers more solutions for their pharmaceutical outsourcing needs. It also gives us greater capacity to increase production and explore new markets.”